ImmunologybioRxivPreprint
SARS-CoV-2 mRNA vaccine is re-adenylated in vivo, enhancing antigen production and immune response
P. S. Krawczyk, O. Gewartowska, M. Mazur…·S. Mroczek
This study shows that SARS-CoV-2 mRNA vaccines are re-adenylated in vivo, increasing antigen production and immune response in macrophages.
DOI 10.1101/2022.12.01.518149